SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : North American Vaccine (NVX)
NVX 1.015-1.9%Dec 31 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: andy harrison who wrote (8)12/19/1996 10:37:00 PM
From: Don W Stone   of 35
 
Andy; I agree.

and, January just could be the month !!!!!!

Of course '96 hasn't been all that bad for the NVX investor.

Last January NVX was around $12-$13. The stock could end UP 100% .

I do believe though that when North American Vaccines gets this FDA approval sometime in the next month or two, the following in the stock will change dramatically.
I also think that there will be more than just three (3) big drug companies out there showing alot of interest in NVX.
There is alot of talk about all types of vaccines today in the local papers, on national news, in various magazines, etc.
NVX is a pure play in several potentially lucrative parts of the vaccine business with some leading vaccine technologies and they are starting to draw some attention ( i.e. Strep B/ Harvard Med.11/96 ).

YES, 1997 JUST COULD BE OUR YEAR!!!! We could end out UP 150% :-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext